News

Patients in England with severe beta-thalassaemia will be amongst the first in Europe to benefit from one-time gene therapy exagamglogene autotemcel (“exa-cel”, also called Casgevy and made by Vertex).

This may come as a surprise, but the BCG vaccine against tuberculosis is the oldest immunotherapy against cancer. Now, a team from the Champalimaud Foundation, in Lisbon, has found the first steps of its action to destroy cancer cells.

A new study looks into how deficiency of the enzyme NMNAT2 renders the nerve cells of the eye vulnerable to neurodegeneration and could be a key in the search for a treatment.

A team of researchers has discovered two new ways of preventing and treating respiratory viruses. The team reports the development and validation of NanoSTING, a nasal spray, and the development of NanoSTING-SN, a pan-coronavirus nasal vaccine.

Alterations in the composition of immune cells in multiple myeloma patients can influence the efficacy of vaccines, a new immune atlas reveals.

Researchers at the University of Helsinki and HUS Helsinki University Hospital succeeded in creating cells whose proliferation can be controlled. The technique enables new and safe cell therapies.

A team of research groups discovered that a migration path used by cells during brain development can be hijacked for cancer cell invasion, opening up new opportunities for treating aggressive brain cancers like glioblastoma.

A new technique to help CAR T-cells persist longer in the body and form a memory of the cancer cell could prevent cancer recurrence.

Ecklonia cava is a seaweed that may hold the key to Parkinson’s disease prevention. In this study, two types of motor function tests were conducted using Parkinson’s disease model mice that were orally fed the antioxidants daily for one week.

Researchers at the University of Sydney and Liverpool School of Tropical Medicine demonstrated how a commonly used blood thinner could be repurposed as a cost-effective and easy-to-access cobra venom antidote.